Torisel 25mg For Intravenous Drip Infusion Special Investigation - Survey On Long-Term Use
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 07 Apr 2017
At a glance
- Drugs Temsirolimus (Primary)
- Indications Renal cell carcinoma
- Focus Therapeutic Use
- Sponsors Pfizer
- 02 Apr 2017 Planned End Date changed from 1 Jul 2015 to 1 Jan 2018.
- 02 Apr 2017 Planned primary completion date changed from 1 Jul 2015 to 1 Jan 2018.
- 02 Apr 2017 Status changed from completed to active, no longer recruiting.